1919.8000 -43.70 (-2.23%)
NSE Sep 26, 2025 15:31 PM
Volume: 1.1M
 

logo
Lupin Ltd.
28 Oct 2015, 12:00AM
1919.80
-2.23%
Chola Wealth Direct
Background: Amongst the largest Pharma companies in domestic market with Net Sales of INR 112.9bn with a strong brand portfolio. R&D; cost is in excess of 8% of Sales. Exports account for 73% with Developed Markets (DM) at 58% and EM at 15%. Sales Mix: API - 10%, Domestic Formulations - 25%, DM Formulations - 56%, EM Formulations - 9%. Historically strong in anti-TB segment, has built expertise in fermentation based products and segments like...
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended